Uchida E - Search Results

1

Aspects of Gene Therapy Products Using Current Genome-Editing Technology in Japan.

Yamaguchi T, Uchida E, Okada T, Ozawa K, Onodera M, Kume A, Shimada T, Takahashi S, Tani K, Nasu Y, Mashimo T, Mizuguchi H, Mitani K, Maki K. Yamaguchi T, et al. Among authors: uchida e. Hum Gene Ther. 2020 Oct;31(19-20):1043-1053. doi: 10.1089/hum.2020.156. Epub 2020 Sep 17. Hum Gene Ther. 2020. PMID: 32731837 Free PMC article. Review.

2

Two-Dimensional Droplet Digital PCR as a Tool for Titration and Integrity Evaluation of Recombinant Adeno-Associated Viral Vectors.

Furuta-Hanawa B, Yamaguchi T, Uchida E. Furuta-Hanawa B, et al. Among authors: uchida e. Hum Gene Ther Methods. 2019 Aug;30(4):127-136. doi: 10.1089/hgtb.2019.031. Epub 2019 Jun 21. Hum Gene Ther Methods. 2019. PMID: 31140327 Free PMC article.

3

Regulatory aspects of oncolytic virus products.

Yamaguchi T, Uchida E. Yamaguchi T, et al. Among authors: uchida e. Curr Cancer Drug Targets. 2007 Mar;7(2):203-8. doi: 10.2174/156800907780058790. Curr Cancer Drug Targets. 2007. PMID: 17346112 Review.

4

Oncolytic Virus: Regulatory Aspects from Quality Control to Clinical Studies.

Yamaguchi T, Uchida E. Yamaguchi T, et al. Among authors: uchida e. Curr Cancer Drug Targets. 2018;18(2):202-208. doi: 10.2174/1568009617666170222142650. Curr Cancer Drug Targets. 2018. PMID: 28228083 Review.

5

CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice.

Mizuguchi H, Koizumi N, Hosono T, Ishii-Watabe A, Uchida E, Utoguchi N, Watanabe Y, Hayakawa T. Mizuguchi H, et al. Among authors: uchida e. Gene Ther. 2002 Jun;9(12):769-76. doi: 10.1038/sj.gt.3301701. Gene Ther. 2002. PMID: 12040458

6

Detection of replication-competent adenoviruses spiked into recombinant adenovirus vector products by infectivity PCR.

Ishii-Watabe A, Uchida E, Iwata A, Nagata R, Satoh K, Fan K, Murata M, Mizuguchi H, Kawasaki N, Kawanishi T, Yamaguchi T, Hayakawa T. Ishii-Watabe A, et al. Among authors: uchida e. Mol Ther. 2003 Dec;8(6):1009-16. doi: 10.1016/j.ymthe.2003.09.001. Mol Ther. 2003. PMID: 14664804 Free article.

7

Optimization of transcriptional regulatory elements for constructing plasmid vectors.

Xu ZL, Mizuguchi H, Ishii-Watabe A, Uchida E, Mayumi T, Hayakawa T. Xu ZL, et al. Among authors: uchida e. Gene. 2001 Jul 11;272(1-2):149-56. doi: 10.1016/s0378-1119(01)00550-9. Gene. 2001. PMID: 11470520

8

Comparison of the efficiency and safety of non-viral vector-mediated gene transfer into a wide range of human cells.

Uchida E, Mizuguchi H, Ishii-Watabe A, Hayakawa T. Uchida E, et al. Biol Pharm Bull. 2002 Jul;25(7):891-7. doi: 10.1248/bpb.25.891. Biol Pharm Bull. 2002. PMID: 12132664 Free article.

9

IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector.

Mizuguchi H, Xu Z, Ishii-Watabe A, Uchida E, Hayakawa T. Mizuguchi H, et al. Among authors: uchida e. Mol Ther. 2000 Apr;1(4):376-82. doi: 10.1006/mthe.2000.0050. Mol Ther. 2000. PMID: 10933956 Free article.

10

[Viral safety of biologicals: evaluation of hepatitis C virus (HCV) nucleic acid amplification test (NAT) assay and development of concentration method of HCV for sensitive detection by NAT].

Uchida E, Yamaguchi T. Uchida E, et al. Yakugaku Zasshi. 2010 Feb;130(2):163-9. doi: 10.1248/yakushi.130.163. Yakugaku Zasshi. 2010. PMID: 20118638 Free article. Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

649 results

Search Page